December 22, 2025, Madison, WI — Scarab Genomics is pleased to announce a new distribution partnership with World Fusion, which will serve as the authorized distributor of Scarab Genomics technologies in the Japanese market. Through this collaboration, researchers and biomanufacturing organizations in Japan will gain expanded access to the Clean Genome^® E. coli platform from Scarab Genomics, supported by regional expertise and local engagement.

As demand continues to grow for reliable, high-performance microbial systems and bioprocess technologies across protein expression, plasmid DNA production, and a range of recombinant and biomanufacturing applications, Scarab Genomics identified World Fusion as a strong partner with deep experience supporting life science organizations in Japan. Their understanding of local scientific needs and commitment to technical excellence align closely with the approach Scarab Genomics takes to customer collaboration.

“Scarab Genomics technologies are designed to support demanding microbial expression and bioprocess workflows by improving genomic stability and expression consistency,” said Charles Landry, PhD, Chief Scientific Officer at Scarab Genomics. “World Fusion understands the technical requirements of researchers and manufacturers in Japan and is well positioned to support adoption of Clean Genome^®–based systems.”

“We are pleased to partner with Scarab Genomics,” said Kozo Kawahar, CEO at World Fusion. “The Scarab Genomics technology portfolio addresses key challenges in stability, consistency, and scalability across microbial expression and bioprocessing. We look forward to supporting customers in Japan and helping broaden adoption of these technologies.”